NCT00116064View on ClinicalTrials.gov

Intranasal Lorazepam Versus Intramuscular Paraldehyde in Paediatric Convulsions

PHASE3CompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

June 30, 2005

Conditions
Status EpilepticusConvulsions
Interventions
DRUG

intranasal lorazepam

DRUG

intramuscular paraldehyde

Trial Locations (1)

Unknown

Paediatric Emergency Department, Queen Elizabeth Central Hospital, Blantyre

All Listed Sponsors
lead

Kamuzu University of Health Sciences

OTHER

NCT00116064 - Intranasal Lorazepam Versus Intramuscular Paraldehyde in Paediatric Convulsions | Biotech Hunter | Biotech Hunter